Codexis (CDXS)
(Delayed Data from NSDQ)
$2.98 USD
0.00 (0.00%)
Updated Jul 9, 2024 04:00 PM ET
After-Market: $2.98 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth C Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CDXS 2.98 0.00(0.00%)
Will CDXS be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for CDXS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CDXS
Codexis (CDXS) Tops Q4 Earnings and Revenue Estimates
Can Low Occupancy Rate Affect Select Medical (SEM) Q4 Earnings?
CDXS: What are Zacks experts saying now?
Zacks Private Portfolio Services
ANSYS (ANSS) to Report Q4 Earnings: Here's What to Expect
WIX Set to Report Q4 Earnings: Here's What You Should Know
Higher Visits to Soften Cost Blow for Teladoc (TDOC) Q4 Earnings
Other News for CDXS
Codexis Finalizes Purchase Agreement with Crosswalk Therapeutics for Gene Therapy Assets
Codexis assumed with a Buy at Jefferies
Cantor starts Codexis at Overweight into stock-moving catalysts
Codexis initiated with bullish view at Cantor Fitzgerald
CDXS, SMMT and OABI are among after hour movers